NASDAQ:ACER Investor Notice: Lawsuit Alleges False and Misleading Statements by Acer Therapeutics Inc.
An investor, who purchased shares of Acer Therapeutics Inc. (NASDAQ: ACER), filed a lawsuit over alleged Securities Laws violations by Acer Therapeutics Inc..
View full press release